NovoEight 1000 IU (Turoctocog Alfa)

NovoEight 1000 IU (Turoctocog Alfa) is a prescription medicine used for the treatment and prevention of bleeding episodes in individuals with Hemophilia A (congenital Factor VIII deficiency). It contains Turoctocog Alfa, a recombinant coagulation Factor VIII, designed to replace the missing or defective clotting protein in the blood.

Active Ingredient:

NovoEight contains Turoctocog Alfa, a recombinant Factor VIII (rFVIII) produced using advanced biotechnology. It is structurally and functionally similar to natural human Factor VIII, and is free from human or animal-derived components, reducing the risk of infections or immune reactions.

Each vial of NovoEight delivers 1000 IU (International Units) of Factor VIII activity after reconstitution.

Dosage:

The dosage of NovoEight 1000 IU is based on the patient’s weight, the severity of Factor VIII deficiency, and the type of bleeding episode. It is administered as an intravenous injection under the supervision of a healthcare professional or as self-infusion by trained patients or caregivers.

• On-demand treatment for bleeding episodes
• Preventive (prophylactic) therapy to reduce the frequency of bleeds
• Perioperative management to control bleeding during and after surgeries

Always follow your doctor’s guidance on dosing and administration.

Usage:

NovoEight is indicated for:

• Treatment and control of bleeding in patients with Hemophilia A
• Routine prophylaxis to prevent bleeding episodes
• Management of bleeding during surgical procedures

It is not indicated for the treatment of von Willebrand disease or Hemophilia B (Factor IX deficiency).

Effectiveness:

NovoEight (Turoctocog Alfa) has been proven effective in:

• Promptly stopping bleeding episodes
• Preventing spontaneous joint and muscle bleeds when used regularly
• Managing blood loss during surgeries

It has a favorable safety profile with a low risk of inhibitor development. Common side effects may include injection site reactions, fever, or mild allergic symptoms. Patients should be monitored for Factor VIII inhibitors, especially during early treatment.

Delivery Process:

We ship your medication worldwide within 2–10 days. All products are packaged securely and shipped according to international pharmaceutical shipping standards, including cold-chain management if required. Orders are typically dispatched within 48 hours after payment confirmation. A unique tracking number will be shared post-shipment.

Mode of shipment: EMS / Aramex / DHL / India Post / UPS / FEDEX / Delhivery
Mode of payment: Wire transfer / Telegraphic transfer / Western Union / Ria

Note:

This description is for informational purposes only and does not replace professional medical advice. Always consult your physician or a qualified healthcare provider before starting or altering any treatment. Use NovoEight 1000 IU only as prescribed and under proper medical supervision.

Attention:

Prices are subject to change depending on quantity required or bulk order. To get the best discounted prices or know more about our latest offers, please visit our Contact Us page or get in touch with our support team directly.